China Shineway Pharmaceutical Group Limited (HKG:2877)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.24
+0.01 (0.11%)
Mar 10, 2026, 3:59 PM HKT
8.07%
Market Cap 6.97B
Revenue (ttm) 3.66B
Net Income (ttm) 907.56M
Shares Out 755.40M
EPS (ttm) 1.20
PE Ratio 7.71
Forward PE 7.42
Dividend 0.51 (5.53%)
Ex-Dividend Date n/a
Volume 482,000
Average Volume 768,881
Open 9.31
Previous Close 9.23
Day's Range 9.24 - 9.38
52-Week Range 6.96 - 10.01
Beta 0.87
RSI 49.19
Earnings Date Mar 27, 2026

About HKG:2877

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, ortho... [Read more]

Sector Healthcare
Founded 2002
Employees 2,867
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2877
Full Company Profile

Financial Performance

In 2024, HKG:2877's revenue was 3.78 billion, a decrease of -16.35% compared to the previous year's 4.52 billion. Earnings were 840.05 million, a decrease of -13.35%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.